|
|
Considering aesthetic surgery? You need to do your research and become an informed consumer.
Home
Information about Anti-Aging Products and Their Active
Ingredients
WRINKLE RELAX
HYDRODERM
Strivectin Eye Cream Celebrity Plastic
Surgery Celebrity Cosmetic Surgery Whose Had it??
Bion Ceramic Flat Iron
GoSMILE TOOTH WHITENING
FROWNIES
HOLLYWOOD'S BEST
KEPT SECRET
RICAUD |
Brava System Used In New Study 'Breast Augmentation With Grafting Of Liposuctioned Fat: A Safe And Effective Procedure' (press release from Brava, LLC) The Brava System, the only clinically proven device for non-surgical breast augmentation, is part of a leading edge study that offers women a new minimally invasive option for breast augmentation and reconstruction. The study, "Breast Augmentation With Grafting of Liposuctioned Fat: A Safe and Effective Procedure," is being conducted by Roger K. Khouri, M.D., Steven E. Chavoustie, M.D. and Macarena Carretero, M.D. The preliminary findings will be presented today at the American College of Obstetricians and Gynecologists (ACOG) 55th Annual Clinical Meeting in San Diego. Until now, women have had two clinically-proven options available for breast augmentation: surgical breast implants and a non-surgical enhancement through the use of an external tissue expansion device. In this study, physicians utilize autologous fat to reshape and augment the breasts. Historically, autologous fat injection in breast augmentation was controversial and banned in 1987 by the American Society of Plastic and Reconstructive Surgeon's Ad-Hoc Committee on New Procedures. The Committee's opinion stipulated that much of the injected fat would not survive and the physiologic response to fat necrosis was scarring and calcification, thus making mammography difficult to interpret. Today, with advancements in breast imaging, the harvesting of tissue, more refined surgical cannulas and improved preparation of the recipient graft site, this procedure is now a viable option for breast augmentation. For this procedure, patients are treated pre-operatively and post-operatively using Brava, an external tissue expander, to prepare, and later stent, the recipient site. The single-stage, large-volume lipotransfer breast augmentation notes a graft survival rate of 90% in the prepared, expanded, hypervascularized tissue bed. While the study is on-going, the 25 reported patients who have gone through the process have had increases of between 90 to 300 ml per breast (approximately 1 to 2-1/2 cup sizes). "OB/GYNs are frequently asked by their patients about breast augmentation and reconstruction", says Dr. Chavoustie. "Traditionally, there were only two alternatives we could offer our patients, breast implant surgery or a non-surgical breast expansion device. Now, this new procedure, which is both safe and effective, offers the benefit of a natural (autologous) fat filler, which will not affect breast imaging, and has the added benefit of target site liposuctioning. Dr. Chavoustie goes on to explain, "Not only are we looking at this new cutting edge procedure as a cosmetic alternative, but also for future reconstructive applications for patients with status-post lumpectomy filling defects or breast asymmetry." Dr. Steven Chavoustie, Physician Director of Research and Development at Brava, LLC, will be present at the ACOG's Annual Clinical Meeting, Poster Presentation #98, to discuss the study in more detail on Tuesday afternoon, May 8th. He will also be available at booth #436 (Brava, LLC) Monday, May 7th and Wednesday, May 9th.
For more information about the Brava System, please visit the Brava Web site,
About the Study Investigators |
PROACTIV SOLUTION ACNE TREATMENT
|
|
Type in your search words below
|